—VTR
— • —
$83.81
P/E
154.60
PEG
0.01
FCF Yield
—
Rev Growth YoY
+1847.0% YoY
Gross Margin
4138.0%
Health Score
3/10
D/E Ratio
1.01
Confidence
LOW
Business Snapshot
The ticker and company name are not identified in this data payload, and exchange, sector, and industry fields are all blank. Based on available financial data, this appears to be a company that has undergone extraordinary growth — revenue up 1,847% year-over-year — suggesting either a very early-stage business, a recent transformational acquisition, or a company emerging from near-zero revenue. With no market capitalisation data available, a definitive cap-tier classification cannot be made, though the current price of $83.81 and the available valuation ratios suggest a small-to-mid-cap profile.
Financial Health
**Score: 3/10** The financial health picture is deeply concerning despite headline growth figures. The current ratio of 0.22x is critically low — a ratio below 1.0x means the company holds only $0.22 in short-term assets for every $1.00 of short-term liabilities, signalling potential near-term liquidity stress...
Risk Assessment
- **LIQUIDITY:** Current ratio of 0.22x is critically below the safety threshold of 1.0x, suggesting the company may struggle to meet short-term obligations. - **VALUATION:** P/E of 154.6x is approximately 6x the sector average of 25x, pricing in near-perfect execution with no margin for error. - **CASH FLOW:** Free cash flow is unavailable and the Python DCF flags negative FCF, meaning reported profitability may not be backed by real cash generation. - **DATA OPACITY:** No TTM Revenue, TTM Net Income, quarterly financials, or market cap data are available, severely limiting fundamental analysis reliability. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) is a classical bearish momentum signal, and MACD is also bearish — both moving-average reference prices are unavailable, adding uncertainty. ---...